RESEARCHER PROFILE
Thomas Patrick Johnston
← Back to University of Missouri–Kansas City
T
University of Missouri–Kansas City
Thomas Patrick Johnston works in Cholesterol and Lipid Metabolism, Synthesis and biological activity, Lipoproteins and Cardiovascular Health, Advanced Drug Delivery Systems, Curcumin's Biomedical Applications. Recorded institutional associations include University of Missouri–Kansas City.
275Publications
13,087Citations
60H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
The impact of stress on body function: a review
2017 · 1,065 citationsThe use of mucoadhesive polymers in buccal drug delivery
2005 · 691 citationsAnti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
2020 · 379 citationsCOVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up
2020 · 272 citationsTherapeutic effects of curcumin in inflammatory and immune‐mediated diseases: A nature‐made jack‐of‐all‐trades?
2017 · 270 citationsCurcumin use in pulmonary diseases: State of the art and future perspectives
2016 · 258 citationsCurcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms
2016 · 248 citationsCurcumin as a MicroRNA Regulator in Cancer: A Review
2016 · 226 citationsEvidence of curcumin and curcumin analogue effects in skin diseases: A narrative review
2018 · 222 citationsCurcumin, hemostasis, thrombosis, and coagulation
2017 · 219 citationsCurcumin: A natural modulator of immune cells in systemic lupus erythematosus
2017 · 211 citationsCurcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features
2016 · 192 citationsThe Modes of Decomposition of 1,3-Bis(2-chloroethyl)-1-nitrosourea and Related Compounds
1967 · 175 citations1,3-Bis(2-Chloroethyl)-1-Nitrosourea (Bcnu) And Other Nitrosoureas In Cancer Treatment: A Review
1973 · 168 citationsSustained Delivery of Interleukin-2 from a Poloxamer 407 Gel Matrix Following Intraperitoneal Injection in Mice
1992 · 167 citationsCurcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases
2023 · 157 citationsCurrent strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium
2005 · 156 citationsColon cancer stem cells: Potential target for the treatment of colorectal cancer
2019 · 143 citationsAtherosclerosis and immunity: A perspective
2018 · 135 citationsBiological Activity of Urease Formulated in Poloxamer 407 after Intraperitoneal Injection in the Rat
1992 · 133 citationsThe Molecular Basis of Retinoid Absorption
2008 · 126 citationsPoloxamer 407-induced atherogenesis in the C57BL/6 mouse
1998 · 121 citationsExosomes: Nanoparticulate tools for RNA interference and drug delivery
2017 · 118 citationsThe beneficial therapeutic effects of plant‐derived natural products for the treatment of sarcopenia
2022 · 115 citationsMacromolecular binding and metabolism of the carcinogen 1,2-dibromoethane.
1978 · 114 citations
